Perspective in Chronic Kidney Disease: Targeting Hypoxia-Inducible Factor (HIF) as Potential Therapeutic Approach

REFERENCES

• Brezis M, Rosen S, Silva P, Epstein FH. Renal ischemia: A new perspective. Kidney Int. 1984;26:375–383.
   PubMed Web of Science ®Google Scholar
• Lubbers DW, Baumgartl H. Heterogeneities and profiles of oxygen pressure in brain and kidney as examples of the pO2 distribution in the living tissue. Kidney Int. 1997;51:372–380.
   Google Scholar
• Zhang W, Edwards A. Oxygen transport across vasa recta in the renal medulla. Am J Physiol Heart Circ Physiol. 2002;283:H1042–H1055.
   PubMed Web of Science ®Google Scholar
• Schurek HJ, Jost U, Baumgartl H, . Evidence for a preglomerular oxygen diffusion shunt in rat renal cortex. Am J Physiol. 1990;259:F910–F915.
   PubMedGoogle Scholar
• Brezis M, Rosen S. Hypoxia of the renal medulla—its implications for disease. N Engl J Med. 1995;332:647–655.
   PubMed Web of Science ®Google Scholar
• Semenza GL. Hypoxia-inducible factor 1: Master regulator of O2 homeostasis. Curr Opin Genet Dev. 1998;8:588–594.
   PubMed Web of Science ®Google Scholar
• Semenza GL. HIF-1, O(2), and the 3 PHDs: How animal cells signal hypoxia to the nucleus. Cell. 2001;107:1–3.
   PubMed Web of Science ®Google Scholar
• Zhu H, Bunn HF. Signal transduction: How do cells sense oxygen? Science. 2001;292:449–451.
   PubMedGoogle Scholar
• Maxwell P. HIF-1: An oxygen response system with special relevance to the kidney. J Am Soc Nephrol. 2003;14:2712–2722.
   PubMed Web of Science ®Google Scholar
• Carmeliet P, Dor Y, Herbert JM, . Role of HIF-1alpha in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis. Nature. 1998;394:485–490.
   PubMed Web of Science ®Google Scholar
• Greijer AE, Van Derwall E. The role of hypoxia inducible factor 1 (HIF-1) in hypoxia induced apoptosis. J Clin Pathol. 2004;57:1009–1014.
   PubMed Web of Science ®Google Scholar
• Bruick RK, McKnight SL. A conserved family of prolyl-4-hydroxylases that modify HIF. Science. 2001;294:1337–1340.
   PubMed Web of Science ®Google Scholar
• Epstein AC, Gleadle JM, McNeill LA, . C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation. Cell. 2001;107:43–54.
   PubMed Web of Science ®Google Scholar
• Ivan M, Kondo K, Yang H, . HIF alpha targeted for VHL mediated destruction by proline hydroxylation: Implications for O2 sensing. Science. 2001;292:464–468.
   PubMed Web of Science ®Google Scholar
• Jaakkola P, Mole DR, Tian YM, . Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation. Science. 2001;292:468–472.
   PubMed Web of Science ®Google Scholar
• Ehrismann D, Flashman E, Genn DN, . Studies on the activity of the hypoxia-inducible-factor hydroxylases using an oxygen consumption assay. Biochem J. 2007;401:227–234.
   PubMed Web of Science ®Google Scholar
• Koivunen P, Hirsila M, Kivirikko KI, Myllyharju J. The length of peptide substrates has a marked effect on hydroxylation by the hypoxia-inducible factor prolyl 4-hydroxylases. J Biol Chem. 2006;281:28712–28720.
   PubMed Web of Science ®Google Scholar
• Kaelin Jr, WG, Ratcliffe PJ. Oxygen sensing by metazoans: The central role of the HIF hydroxylase pathway. Mol Cell. 2008;30:393–402.
   PubMed Web of Science ®Google Scholar
• Carbia-Nagashima A, Gerez J, Perez-Castro C, . RSUME, a small RWD-containing protein, enhances SUMO conjugation and stabilizes HIF-1alpha during hypoxia. Cell. 2007;131:309–323.
   PubMed Web of Science ®Google Scholar
• Bae SH, Jeong JW, Park JA, . Sumoylation increases HIF-1alpha stability and its transcriptional activity. Biochem Biophys Res Commun. 2004;324:394–400.
   PubMed Web of Science ®Google Scholar
• Berta MA, Mazure N, Hattab M, Pouyssegur J, Brahimi-Horn MC. SUMOylation of hypoxia-inducible factor-1alpha reduces its transcriptional activity. Biochem Biophys Res Commun. 2007;360:646–652.
   PubMed Web of Science ®Google Scholar
• Cheng J, Kang X, Zhang S, Yeh ET. SUMO specific protease 1 is essential for stabilization of HIF1alpha during hypoxia. Cell. 2007;131:584–595.
   PubMed Web of Science ®Google Scholar
• Mekhail K, Khacho M, Gunaratnam L, Lee S. Oxygen sensing by H+: Implications for HIF and hypoxic cell memory. Cell Cycle. 2004;3:1027–1029.
   PubMedGoogle Scholar
• Mekhail K, Gunaratnam L, Bonicalzi ME, Lee S. HIF activation by pH-dependent nucleolar sequestration of VHL. Nat Cell Biol. 2004;6:642–647.
   PubMed Web of Science ®Google Scholar
• Ema M, Taya S, Yokotani N, Sogawa K, Matsuda Y, Fujii-Kuriyama Y. A novel bHLH-PAS factor with close sequence similarity to hypoxia-inducible factor 1alpha regulates the VEGF expression and is potentially involved in lung and vascular development. Proc Natl Acad Sci USA. 1997;94:4273–4278.
   PubMed Web of Science ®Google Scholar
• Flamme I, Frohlich T, von Reutern M, Kappel A, Damert A, Risau W. HRF, a putative basic helix-loop-helix-PAS-domain transcription factor is closely related to hypoxia-inducible factor-1 alpha and developmentally expressed in blood vessels. Mech Dev. 1997;63:51–60.
   PubMed Web of Science ®Google Scholar
• Hogenesch JB, Chan WK, Jackiw VH, . Characterization of a subset of the basic-helix-loop-helix-PAS superfamily that interacts with components of the dioxin signaling pathway. J Biol Chem. 1997;272:8581–8593.
   PubMed Web of Science ®Google Scholar
• Tian H, McKnight SL, Russell DW. Endothelial PAS domain protein 1 (EPAS1), a transcription factor selectively expressed in endothelial cells. Genes Dev. 1997;11:72–82.
   PubMed Web of Science ®Google Scholar
• O’Rourke JF, Tian YM, Ratcliffe PJ, Pugh CW. Oxygen-regulated and transactivating domains in endothelial PAS protein 1: Comparison with hypoxia-inducible factor-1alpha. J Biol Chem. 1999;274:2060–2071.
   PubMed Web of Science ®Google Scholar
• Mahon PC, Hirota K, Semenza GL. FIH-1. A novel protein that interacts with HIF-1alpha and VHL to mediate repression of HIF-1 transcriptional activity. Genes Dev. 2001;15:2675–2686.
   PubMed Web of Science ®Google Scholar
• Wiesener MS, Turley H, Allen WE, . Induction of endothelial PAS domain protein-1 by hypoxia: Characterization and comparison with hypoxia inducible factor-1alpha. Blood. 1998;92:2260–2268.
   PubMed Web of Science ®Google Scholar
• Hewitson KS, McNeill LA, Riordan MV, . Hypoxia-inducible factor (HIF) asparagine hydroxylase is identical to factor inhibiting HIF (FIH) and is related to the cupin structural family. J Biol Chem. 2002;277:26351–26355.
   PubMed Web of Science ®Google Scholar
• Lando D, Peet DJ, Gorman JJ, Whelan DA, Whitelaw ML, Bruick RK. FIH-1 is an asparaginyl hydroxylase enzyme that regulates the transcriptional activity of hypoxia-inducible factor. Genes Dev. 2002;16:1466–1471.
   PubMed Web of Science ®Google Scholar
• Dayan F, Roux D, Brahimi-Horn MC, Pouyssegur J, Mazure NM. The oxygen sensor factor-inhibiting hypoxia-inducible factor-1 controls expression of distinct genes through the bifunctional transcriptional character of hypoxia-inducible factor-1alpha. Cancer Res. 2006;66:3688–3698.
   PubMed Web of Science ®Google Scholar
• Koivunen P, Hirsila M, Gunzler V, Kivirikko KI, Myllyharju J. Catalytic properties of the asparaginyl hydroxylase (FIH) in the oxygen sensing pathway are distinct from those of its prolyl 4-hydroxylases. J Biol Chem. 2004;279:9899–9904.
   PubMed Web of Science ®Google Scholar
• Appelhoff RJ, Tian YM, Raval RR, . Differential function of the prolyl hydroxylases PHD1, PHD2, and PHD3 in the regulation of hypoxia-inducible factor. J Biol Chem. 2004;279:38458–38465.
   PubMed Web of Science ®Google Scholar
• Gardner HF. The use of cobaltous chloride in the anemia associated with chronic renal disease. J Lab Clin Med. 1953;41:56–64.
   PubMed Web of Science ®Google Scholar
• Matsumoto M, Makino Y, Tanaka T, . Induction of renoprotective gene expression by cobalt ameliorates ischemic injury of the kidney in rats. J Am Soc Nephrol. 2003;14:1825–1832.
   PubMed Web of Science ®Google Scholar
• Tanaka T, Matsumoto M, Inagi R, . Induction of renoprotective gene expression by cobalt ameliorates tubulointerstitial injury in the progressive Thy1 nephritis model. Kidney Int. 2005;68(6):2714–2725.
   PubMed Web of Science ®Google Scholar
• Tanaka T, Kojima I, Ohse T, . Hypoxia-inducible factor (HIF) modulates tubular cell survival in cisplatin nephrotoxicity. Am J Physiol Renal Physiol. 2005;289:F1123–F1133.
   Web of Science ®Google Scholar
• Tanaka T, Kojima I, Ohse T, . Cobalt promotes angiogenesis via hypoxia inducible factors and protects ischemic tubulointerstitium in the remnant kidney. Lab Invest. 2005;85:1292–1307.
   PubMed Web of Science ®Google Scholar
• Warnecke C, Griethe W, Weidemann A, . Activation of the hypoxia-inducible factor-pathway and stimulation of angiogenesis by application of prolyl hydroxylase inhibitors. FASEB J. 2003;17:1186–1188.
   PubMed Web of Science ®Google Scholar
• Ryan HE, Lo J, Johnson RS. HIF-1 alpha is required for solid tumor formation and embryonic vascularization. EMBO J. 1998;17:3005–3015.
   PubMed Web of Science ®Google Scholar
• Iyer NV, Kotch LE, Agani F, . Cellular and developmental control of O2 homeostasis by hypoxia-inducible factor 1 alpha. Genes Dev. 1998;12:149–162.
   PubMed Web of Science ®Google Scholar
• Doedens A, Johnson RS. Transgenic models to understand hypoxia-inducible factor function. Methods Enzymol. 2007;435:87–105.
   Google Scholar
• Peng J, Zhang L, Drysdale L, Fong GH. The transcription factor EPAS-1/hypoxia-inducible factor 2alpha plays an important role in vascular remodeling. Proc Natl Acad Sci USA. 2000;97:8386–8391.
   PubMedGoogle Scholar
• Maltepe E, Schmidt JV, Baunoch D, Bradfield CA, Simon MC. Abnormal angiogenesis and responses to glucose and oxygen deprivation in mice lacking the protein ARNT. Nature. 1997;386:403–407.
   PubMed Web of Science ®Google Scholar
• Steenhard BM, Freeburg PB, Isom K, . Kidney development and gene expression in the HIF2alpha knockout mouse. Dev Dyn. 2007;236:1115–1125.
   PubMed Web of Science ®Google Scholar
• Ferrara N, Carver-Moore K, Chen H, . Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature. 1996;380:439–442.
   PubMed Web of Science ®Google Scholar
• Carmeliet P, Ferreira V, Breier G, . Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature. 1996;380:435–439.
   PubMed Web of Science ®Google Scholar
• Kitamoto Y, Tokunaga H, Tomita K. Vascular endothelial growth factor is an essential molecule for mouse kidney development: Glomerulogenesis and nephrogenesis. J Clin Invest. 1997;99:2351–2357.
   PubMed Web of Science ®Google Scholar
• Eremina V, Sood M, Haigh J, . Glomerular-specific alterations of VEGF-A expression lead to distinct congenital and acquired renal diseases. J Clin Invest. 2003;111:707–716.
   PubMed Web of Science ®Google Scholar
• Eremina V, Quaggin SE. The role of VEGF-A in glomerular development and function. Curr Opin Nephrol Hypertens. 2004;13:9–15.
   PubMed Web of Science ®Google Scholar
• Eremina V, Jefferson JA, Kowalewska J, . VEGF inhibition and renal thrombotic microangiopathy. N Engl J Med. 2008;358:1129–1136.
   PubMed Web of Science ®Google Scholar
• Risdon RA, Sloper JC, De Wardener HE. Relationship between renal function and histological changes found in renal-biopsy specimens from patients with persistent glomerular nephritis. Lancet. 1968;2:363–366.
   PubMed Web of Science ®Google Scholar
• Schainuck LI, Striker GE, Cutler RE, Benditt EP. Structural-functional correlations in renal disease: II. The correlations. Hum Pathol. 1970;1:631–641.
   PubMedGoogle Scholar
• Striker GE, Schainuck LI, Cutler RE, Benditt EP. Structural-functional correlations in renal disease: I. A method for assaying and classifying histopathologic changes in renal disease. Hum Pathol. 1970;1:615–630.
   Google Scholar
• Fine LG, Bandyopadhay D, Norman JT. Is there a common mechanism for the progression of different types of renal diseases other than proteinuria? Towards the unifying theme of chronic hypoxia. Kidney Int Suppl. 2000;75:S22–S26.
   PubMedGoogle Scholar
• Norman JT, Clark IM, Garcia PL. Hypoxia promotes fibrogenesis in human renal fibroblasts. Kidney Int. 2000;58:2351–2366.
   PubMed Web of Science ®Google Scholar
• Manotham K, Tanaka T, Matsumoto M, . Transdifferentiation of cultured tubular cells induced by hypoxia. Kidney Int. 2004;65:871–880.
   PubMed Web of Science ®Google Scholar
• Manotham K, Tanaka T, Matsumoto M, . Evidence of tubular hypoxia in the early phase in the remnant kidney model. J Am Soc Nephrol. 2004;15:1277–1288.
   PubMed Web of Science ®Google Scholar
• Higgins DF, Kimura K, Bernhardt WM, . Hypoxia promotes fibrogenesis in vivo via HIF-1 stimulation of epithelial-to-mesenchymal transition. J Clin Invest. 2007;117:3810–3820.
   PubMed Web of Science ®Google Scholar
• Rankin EB, Tomaszewski JE, Haase VH. Renal cyst development in mice with conditional inactivation of the von Hippel-Lindau tumor suppressor. Cancer Res. 2006;66:2576–2583.
   PubMed Web of Science ®Google Scholar
• Raval RR, Lau KW, Tran MG, . Contrasting properties of hypoxia-inducible factor 1 (HIF-1) and HIF-2 in von Hippel-Lindau-associated renal cell carcinoma. Mol Cell Biol. 2005;25:5675–5686.
   PubMed Web of Science ®Google Scholar
• Hu CJ, Iyer S, Sataur A, Covello KL, Chodosh LA, Simon MC. Differential regulation of the transcriptional activities of hypoxia inducible factor 1 alpha (HIF-1alpha) and HIF-2alpha in stem cells. Mol Cell Biol. 2006;26:3514–3526.
   PubMed Web of Science ®Google Scholar
• Rosenberger C, Mandriota S, Jurgensen JS, . Expression of hypoxia-inducible factor-1alpha and -2alpha in hypoxic and ischemic rat kidneys. J Am Soc Nephrol. 2002;13:1721–1732.
   PubMed Web of Science ®Google Scholar
• Tanaka T, Miyata T, Inagi R, . Hypoxia in renal disease with proteinuria and/or glomerular hypertension. Am J Pathol. 2004;165:1979–1992.
   Google Scholar
• Rosenberger C, Griethe W, Gruber G, . Cellular responses to hypoxia after renal segmental infarction. Kidney Int. 2003;64:874–886.
   PubMed Web of Science ®Google Scholar
• Rosenberger C, Heyman SN, Rosen S, . Up-regulation of HIF in experimental acute renal failure: Evidence for a protective transcriptional response to hypoxia. Kidney Int. 2005;67:531–542.
   PubMed Web of Science ®Google Scholar
• Mazzali M, Jefferson JA, Ni Z, . Microvascular and tubulointerstitial injury associated with chronic hypoxia-induced hypertension. Kidney Int. 2003;63:2088–2093.
   PubMed Web of Science ®Google Scholar
• Johnson RJ, Herrera-Acosta J, Schreiner GF, Rodrigueziturbe B. Subtle acquired renal injury as a mechanism of saltsensitive hypertension. N Engl J Med. 2002;346:913–923.
   PubMed Web of Science ®Google Scholar
• Oliver JA, Maarouf O, Cheema FH, . The renal papilla is a niche for adult kidney stem cells. J Clin Invest. 2004;114:795–804.
   PubMed Web of Science ®Google Scholar
• Adelman DM, Gertsenstein M, Nagy A, . Placental cell fates are regulated in vivo by HIF-mediated hypoxia responses. Genes Dev. 2000;14:3191–3203.
   PubMed Web of Science ®Google Scholar
• Ceradini DJ, Kulkarni AR, Callaghan MJ, . Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1. Nat Med. 2004;10:858–864.
   PubMed Web of Science ®Google Scholar
• Pagel H, Jelkmann W, Weiss C. A comparison of the effects of renal artery constriction and anemia on the production of erythropoietin. Pflugers Arch. 1988;413:62–66.
   PubMedGoogle Scholar
• Hodgkiss RJ. Use of 2-nitroimidazoles as bioreductive markers for tumour hypoxia. Anticancer Drug Des. 1998;13:687–702.
   PubMedGoogle Scholar
• Matsumoto M, Tanaka T, Yamamoto T, . Hypoperfusion of peritubular capillaries induces chronic hypoxia before progression of tubulointerstitial injury in a progressive model of rat glomerulonephritis. J Am Soc Nephrol. 2004;15:1574–1581.
   PubMed Web of Science ®Google Scholar
• Basile DP, Donohoe DL, Roethe K, Mattson DL. Chronic renal hypoxia after acute ischemic injury: Effects of L-arginine on hypoxia and secondary damage. Am J Physiol Renal Physiol. 2003;284:F338–F348.
   Google Scholar
• Priyadarshi A, Periyasamy S, Burke TJ, . Effects of reduction of renal mass on renal oxygen tension and erythropoietin production in the rat. Kidney Int. 2002;61:542–546.
   Google Scholar
• Prasad PV, Edelman RR, Epstein FH. Noninvasive evaluation of intrarenal oxygenation with BOLD MRI. Circulation. 1996;94:3271–3275.
   PubMed Web of Science ®Google Scholar
• Bohle A, von Gise H, Mackensen-Haen S, Stark-Jakob B. The obliteration of the postglomerular capillaries and its influence upon the function of both glomeruli and tubuli. Functional interpretation of morphologic findings. Klin Wochenschr. 1981;59:1043–1051.
   PubMedGoogle Scholar
• Choi YJ, Chakraborty S, Nguyen V, . Peritubular capillary loss is associated with chronic tubulointerstitial injury in human kidney: Altered expression of vascular endothelial growth factor. Hum Pathol. 2000;31:1491–1497.
   PubMed Web of Science ®Google Scholar
• Yuan H-T, Li X-Z, Pitera JE, Long DA, Woolf AS. Peritubular capillary loss after mouse acute nephrotoxicity correlates with down-regulation of vascular endothelial growth factor-A and hypoxia-inducible factor-1alpha. Am J Pathol. 2003;163:2289–2301.
   PubMed Web of Science ®Google Scholar
• Kairaitis LK, Wang Y, Gassmann M, Tay YC, Harris DC. HIF-1alpha expression follows microvascular loss in advanced murine adriamycin nephrosis. Am J Physiol Renal Physiol. 2005;288:F198–F206.
   Google Scholar
• Ohashi R, Kitamura H, Yamanaka N. Peritubular capillary injury during the progression of experimental glomerulonephritis in rats. J Am Soc Nephrol. 2000;11:47–56.
   PubMed Web of Science ®Google Scholar
• Norman JT, Orphanides C, Garcia P, Fine LG. Hypoxia induced changes in extracellular matrix metabolism in renal cells. Exp Nephrol. 1999;7:463–469.
   PubMedGoogle Scholar
• Tanaka T, Hanafusa N, Ingelfinger JR, Ohse T, Fujita T, Nangaku M. Hypoxia induces apoptosis in SV40-immortalized rat proximal tubular cells through the mitochondrial pathways, devoid of HIF-1-mediated upregulation of Bax. Biochem Biophys Res Commun. 2003;309:222–231.
   PubMed Web of Science ®Google Scholar
• Futrakul N, Tohsukhowong P, Patumraj S, Siriviriyakuk P, Tipprukmas N, Futrakul P. Treatments of hemodynamic maladjustment and oxidative stress prevent renal disease progression in chronically severe glomerulonephritides. Ren Fail. 2003;25:839–844.
   PubMed Web of Science ®Google Scholar
• Futrakul N, Vongthavarawat V, Sirisalipotch S, Chairatanarat T, Futrakul P, Suwanwalaikorn S. Tubular dysfunction and hemodynamic alteration in normoalbuminuric type 2 diabetes. Clin Hemorheol Microcirc. 2005;32:59–65.
   PubMed Web of Science ®Google Scholar
• Lombardi D, Gordon KL, Polinsky P, Suga S, Schwartz SM, Johnson RJ. Salt-sensitive hypertension develops after short-term exposure to angiotensin II. Hypertension. 1999;33:1013–1019.
   PubMed Web of Science ®Google Scholar
• Shao J, Nangaku M, Miyata T, . Imbalance of T-cell subsets in angiotensin II-infused hypertensive rats with kidney injury. Hypertension. 2003;42:31–38.
   PubMed Web of Science ®Google Scholar
• Astor BC, Muntner P, Levin A, Eustace JA, Coresh J. Association of kidney function with anemia: The Third National Health and Nutrition Examination Survey (1988– 1994). Arch Intern Med. 2002;162:1401–1408.
   PubMed Web of Science ®Google Scholar
• Iseki K, Ikemiya Y, Iseki C, Takishita S. Hematocrit and the risk of developing end-stage renal disease. Nephrol Dial Transplant. 2003;18:899–905.
   PubMed Web of Science ®Google Scholar
• Mohanram A, Zhang Z, Shahinfar S, Keane WF, Brenner BM, Toto RD. Anemia and end-stage renal disease in patients with type 2 diabetes and nephropathy. Kidney Int. 2004;66:1131–1138.
   PubMed Web of Science ®Google Scholar
• Adler S, Huang H. Impaired regulation of renal oxygen consumption in spontaneously hypertensive rats. J Am Soc Nephrol. 2002;13:1788–1794.
   Google Scholar
• Welch WJ, Baumgartl H, Lubbers D, Wilcox CS. Nephron pO2 and renal oxygen usage in the hypertensive rat kidney. Kidney Int. 2001;59:230–237.
   PubMed Web of Science ®Google Scholar
• Palm F, Cederberg J, Hansell P, Liss P, Carlsson PO. Reactive oxygen species cause diabetes-induced decrease in renal oxygen tension. Diabetologia. 2003;46:1153–1160.
   PubMed Web of Science ®Google Scholar
• Welch WJ, Blau J, Xie H, Chabrashvili T, Wilcox CS. Angiotensin-induced defects in renal oxygenation: Role of oxidative stress. Am J Physiol Heart Circ Physiol. 2005;288:H22–H28.
   PubMed Web of Science ®Google Scholar
• Adler S, Huang H, Wolin MS, Kaminski PM. Oxidant stress leads to impaired regulation of renal cortical oxygen consumption by nitric oxide in the aging kidney. J Am Soc Nephrol. 2004;15:52–60.
   PubMed Web of Science ®Google Scholar
• Ries M, Basseau F, Tyndal B, . Renal diffusion and BOLD MRI in experimental diabetic nephropathy. Blood oxygen level dependent. J Magn Reson Imaging. 2003;17:104–113.
   Web of Science ®Google Scholar
• Kielstein JT, Fliser D. The past, presence and future of ADMA in nephrology. Nephrol Ther. 2007;3:47–54.
   PubMed Web of Science ®Google Scholar
• Tanaka M, Sydow K, Gunawan F, . DDAH overexpression suppresses graft coronary artery disease. Circulation. 2005;112:1549–1556.
   PubMed Web of Science ®Google Scholar
• Jacobi J, Sydow K, von Degenfeld G, . Overexpression of dimethylarginine dimethylaminohydrolase reduces tissue asymmetric dimethylarginine levels and enhances angiogenesis. Circulation. 2005;111:1431–1438.
   PubMed Web of Science ®Google Scholar
• Leiper J, Nandi M, Torondel B, . Disruption of methylarginine metabolism impairs vascular homeostasis. Nat Med. 2007;13:198–203.
   PubMed Web of Science ®Google Scholar
• Segarra G, Medina P, Ballester RM, . Effects of some guanidino compounds on human cerebral arteries. Stroke. 1999;30:2206–2210.
   PubMed Web of Science ®Google Scholar
• Segarra G, Medina P, Vila JM, . Inhibition of nitric oxide activity by arginine analogs in human renal arteries. Am J Hypertens. 2001;14:1142–1148.
   PubMedGoogle Scholar
• Gardiner SM, Kemp PA, Bennett T, . Regional and cardiac hemodynamic effects of NG, NG,dimethyl-L-arginine and their reversibility by vasodilators in conscious rats. Br J Pharmacol. 1993;110:145714–145764.
   Google Scholar
• Kielstein JT, Impraim B, Simmel S, . Cardiovascular effects of systemic nitric oxide synthase inhibition with asymmetrical dimethylarginine in humans. Circulation. 2004;109:172–177.
   PubMed Web of Science ®Google Scholar
• Achan V, Broadhead M, Malaki M, . Asymmetric dimethylarginine causes hypertension and cardiac dysfunction in humans and is actively metabolized by dimethylarginine dimethylaminohydrolase. Arterioscler Thromb Vasc Biol. 2003;23:1455–1459.
   PubMed Web of Science ®Google Scholar
• Kielstein JT, Simmel S, Bode-Boger SM, . Subpressor dose asymmetric dimethylarginine (ADMA) modulates renal function in humans. Kidney Blood Press Res. 2004;27:143–147.
   PubMed Web of Science ®Google Scholar
• Vallance P, Leone A, Calver A, . Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure. Lancet. 1992;339:572–575.
   PubMed Web of Science ®Google Scholar
• Kielstein JT, Boger RH, Bode-Boger SM, . Marked increase of asymmetric dimethylarginine in patients with incipient primary chronic renal disease. J Am Soc Nephrol. 2002;13:170–176.
   PubMed Web of Science ®Google Scholar
• Fliser D, Kronenberg F, Kielstein JT, . Asymmetric dimethylarginine and progression of chronic kidney disease: The mild to moderate kidney disease study. J Am Soc Nephrol. 2005;16:2456–2461.
   PubMed Web of Science ®Google Scholar
• Ravani P, Tripepi G, Malberti F, Testa S, Mallamaci F, Zoccali C. Asymmetrical dimethylarginine predicts progression to dialysis and death in patients with chronic kidney disease: A competing risks modeling approach. J Am Soc Nephrol. 2005;16:2449–2455.
   PubMed Web of Science ®Google Scholar
• Lajer M, Tarnow L, Jorsal A, . Plasma concentration of asymmetric dimethylarginine (ADMA) predicts cardiovascular morbidity and mortality in type 1 diabetic patients with diabetic nephropathy. Diabetes Care. 2008;31:747–752.
   PubMed Web of Science ®Google Scholar
• Hanai K, Babazono T, Nyumura I, . Asymmetric dimethylarginine is closely associated with the development and progression of nephropathy in patients with type 2 diabetes. Nephrol Dial Transplant. 2009;24:1884–1888.
   Google Scholar
• Matsumoto Y, Ueda S, Yamagishi S, . Dimethylarginine dimethylaminohydrolase prevents progression of renal dysfunction by inhibiting loss of peritubular capillaries and tubulointerstitial fibrosis in a rat model of chronic kidney disease. J Am Soc Nephrol. 2007;18:1525–1533.
   PubMed Web of Science ®Google Scholar
• Shibata R, Ueda S, Yamagishi S, . Involvement of asymmetric dimethylarginine (ADMA) in tubulointerstitial ischemia in the early phase of diabetic nephropathy. Nephrol Dial Transplant. 2009;24:1162–1169.
   Google Scholar
• Fliser D, Wagner KK, Loos A, Tsikas D, Haller H. Chronic angiotensin II subtype 1-receptor inhibition reduces (intra)renal vascular resistance in patients with type 2 diabetes mellitus. J Am Soc Nephrol. 2005;16:1135–1140.
   PubMed Web of Science ®Google Scholar
• Aslam S, Santha T, Leone A, Wilcox C. Effects of amlodipine and valsartan on oxidative stress and plasma methylarginines in end-stage renal disease patients on hemodialysis. Kidney Int. 2006;70:2109–2115.
   PubMed Web of Science ®Google Scholar
• Norman JT, Fine LG. Intrarenal oxygenation in chronic renal failure. Clin Exp Pharmacol Physiol. 2006;33:989–996.
   Google Scholar
• Goldfarb M, Rosenberger C, Abassi Z, . Acute-on-chronic renal failure in the rat: Functional compensation and hypoxia tolerance. Am J Nephrol. 2006;26:22–33.
   PubMed Web of Science ®Google Scholar
• Rosenberger C, Goldfarb M, Khamaisi M, . Acute kidney injury in the diabetic rat: Studies in the isolated perfused and intact kidney. Am J Nephrol. 2008;28:831–839.
   PubMed Web of Science ®Google Scholar
• Melin J, Hellberg O, Fellstrom B. Hyperglycaemia and renal ischemia-reperfusion injury. Nephrol Dial Transplant. 2003;18:460–462.
   PubMed Web of Science ®Google Scholar
• Rosenberger C, Shina A, Rosen S, Goldfarb M, Eckardt K, Heyman SN. Hypoxia inducible factors and tubular cell survival in isolated perfused kidneys. Kidney Int. 2006;70:60–70.
   PubMed Web of Science ®Google Scholar
• Doi K, Noiri E, Nakao A, Fujita T, Kobayashi S, Tokunaga K. Functional polymorphisms in the vascular endothelial growth factor gene are associated with development of end-stage renal disease in males. J Am Soc Nephrol. 2006;17:823–830.
   PubMed Web of Science ®Google Scholar